Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar rhabdomyosarcoma

M. Imran Aslam, Simone Hettmer, Jinu Abraham, Dorian Latocha, Anuradha Soundararajan, Elaine T. Huang, Martin W. Goros, Joel E. Michalek, Shuyu Wang, Atiya Mansoor, Brian Druker, Amy J. Wagers, Jeffrey Tyner, Charles Keller

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Since the advent of tyrosine kinase inhibitors as targeted therapies in cancer, several receptor tyrosine kinases (RTK) have been identified as operationally important for disease progression. Rhabdomyosarcoma (RMS) is a malignancy in need of new treatment options; therefore, better understanding of the heterogeneity of RTKs would advance this goal. Here, alveolar RMS (aRMS) tumor cells derived from a transgenic mouse model expressing two such RTKs, platelet-derived growth factor (PDGFR)a and insulin-like growth factor (IGF)-1R, were investigated by fluorescence-activated cell sorting (FACS). Sorted subpopulations that were positive or negative for PDGFRa and IGF-1R dynamically altered their cell surface RTK expression profiles as early as the first cell division. Interestingly, a difference in total PDGFRa expression and nuclear IGF-1R expression was conserved in populations. Nuclear IGF-1R expression was greater than cytoplasmic IGF-1R in cells with initially high cell surface IGF-1R, and cells with high nuclear IGF-1R established tumors more efficiently in vivo. RNA interferencemediated silencing of IGF-1R in the subpopulation of cells initially harboring higher cell surface and total IGF-1R resulted in significantly reduced anchorage-independent colony formation as compared with cells with initially lower cell surface and total IGF-1R expression. Finally, in accordance with the findings observed in murine aRMS, human aRMS also had robust expression of nuclear IGF-1R Implications: RTK expression status and subcellular localization dynamics are important considerations for personalized medicine.

Original languageEnglish (US)
Pages (from-to)1303-1313
Number of pages11
JournalMolecular Cancer Research
Volume11
Issue number11
DOIs
StatePublished - Nov 2013

Fingerprint

Alveolar Rhabdomyosarcoma
Platelet-Derived Growth Factor
Somatomedins
Receptor Protein-Tyrosine Kinases
Protein-Tyrosine Kinases
Neoplasms
Precision Medicine
Rhabdomyosarcoma
Cell Surface Receptors
RNA Interference
Cell Division
Transgenic Mice
Disease Progression
Flow Cytometry

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Oncology

Cite this

Aslam, M. I., Hettmer, S., Abraham, J., Latocha, D., Soundararajan, A., Huang, E. T., ... Keller, C. (2013). Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar rhabdomyosarcoma. Molecular Cancer Research, 11(11), 1303-1313. https://doi.org/10.1158/1541-7786.MCR-12-0598

Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar rhabdomyosarcoma. / Aslam, M. Imran; Hettmer, Simone; Abraham, Jinu; Latocha, Dorian; Soundararajan, Anuradha; Huang, Elaine T.; Goros, Martin W.; Michalek, Joel E.; Wang, Shuyu; Mansoor, Atiya; Druker, Brian; Wagers, Amy J.; Tyner, Jeffrey; Keller, Charles.

In: Molecular Cancer Research, Vol. 11, No. 11, 11.2013, p. 1303-1313.

Research output: Contribution to journalArticle

Aslam, MI, Hettmer, S, Abraham, J, Latocha, D, Soundararajan, A, Huang, ET, Goros, MW, Michalek, JE, Wang, S, Mansoor, A, Druker, B, Wagers, AJ, Tyner, J & Keller, C 2013, 'Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar rhabdomyosarcoma', Molecular Cancer Research, vol. 11, no. 11, pp. 1303-1313. https://doi.org/10.1158/1541-7786.MCR-12-0598
Aslam MI, Hettmer S, Abraham J, Latocha D, Soundararajan A, Huang ET et al. Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar rhabdomyosarcoma. Molecular Cancer Research. 2013 Nov;11(11):1303-1313. https://doi.org/10.1158/1541-7786.MCR-12-0598
Aslam, M. Imran ; Hettmer, Simone ; Abraham, Jinu ; Latocha, Dorian ; Soundararajan, Anuradha ; Huang, Elaine T. ; Goros, Martin W. ; Michalek, Joel E. ; Wang, Shuyu ; Mansoor, Atiya ; Druker, Brian ; Wagers, Amy J. ; Tyner, Jeffrey ; Keller, Charles. / Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar rhabdomyosarcoma. In: Molecular Cancer Research. 2013 ; Vol. 11, No. 11. pp. 1303-1313.
@article{1ce5ac898ec6443aa35b4ca3a0708eab,
title = "Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar rhabdomyosarcoma",
abstract = "Since the advent of tyrosine kinase inhibitors as targeted therapies in cancer, several receptor tyrosine kinases (RTK) have been identified as operationally important for disease progression. Rhabdomyosarcoma (RMS) is a malignancy in need of new treatment options; therefore, better understanding of the heterogeneity of RTKs would advance this goal. Here, alveolar RMS (aRMS) tumor cells derived from a transgenic mouse model expressing two such RTKs, platelet-derived growth factor (PDGFR)a and insulin-like growth factor (IGF)-1R, were investigated by fluorescence-activated cell sorting (FACS). Sorted subpopulations that were positive or negative for PDGFRa and IGF-1R dynamically altered their cell surface RTK expression profiles as early as the first cell division. Interestingly, a difference in total PDGFRa expression and nuclear IGF-1R expression was conserved in populations. Nuclear IGF-1R expression was greater than cytoplasmic IGF-1R in cells with initially high cell surface IGF-1R, and cells with high nuclear IGF-1R established tumors more efficiently in vivo. RNA interferencemediated silencing of IGF-1R in the subpopulation of cells initially harboring higher cell surface and total IGF-1R resulted in significantly reduced anchorage-independent colony formation as compared with cells with initially lower cell surface and total IGF-1R expression. Finally, in accordance with the findings observed in murine aRMS, human aRMS also had robust expression of nuclear IGF-1R Implications: RTK expression status and subcellular localization dynamics are important considerations for personalized medicine.",
author = "Aslam, {M. Imran} and Simone Hettmer and Jinu Abraham and Dorian Latocha and Anuradha Soundararajan and Huang, {Elaine T.} and Goros, {Martin W.} and Michalek, {Joel E.} and Shuyu Wang and Atiya Mansoor and Brian Druker and Wagers, {Amy J.} and Jeffrey Tyner and Charles Keller",
year = "2013",
month = "11",
doi = "10.1158/1541-7786.MCR-12-0598",
language = "English (US)",
volume = "11",
pages = "1303--1313",
journal = "Molecular Cancer Research",
issn = "1541-7786",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Dynamic and nuclear expression of PDGFRα and IGF-1R in alveolar rhabdomyosarcoma

AU - Aslam, M. Imran

AU - Hettmer, Simone

AU - Abraham, Jinu

AU - Latocha, Dorian

AU - Soundararajan, Anuradha

AU - Huang, Elaine T.

AU - Goros, Martin W.

AU - Michalek, Joel E.

AU - Wang, Shuyu

AU - Mansoor, Atiya

AU - Druker, Brian

AU - Wagers, Amy J.

AU - Tyner, Jeffrey

AU - Keller, Charles

PY - 2013/11

Y1 - 2013/11

N2 - Since the advent of tyrosine kinase inhibitors as targeted therapies in cancer, several receptor tyrosine kinases (RTK) have been identified as operationally important for disease progression. Rhabdomyosarcoma (RMS) is a malignancy in need of new treatment options; therefore, better understanding of the heterogeneity of RTKs would advance this goal. Here, alveolar RMS (aRMS) tumor cells derived from a transgenic mouse model expressing two such RTKs, platelet-derived growth factor (PDGFR)a and insulin-like growth factor (IGF)-1R, were investigated by fluorescence-activated cell sorting (FACS). Sorted subpopulations that were positive or negative for PDGFRa and IGF-1R dynamically altered their cell surface RTK expression profiles as early as the first cell division. Interestingly, a difference in total PDGFRa expression and nuclear IGF-1R expression was conserved in populations. Nuclear IGF-1R expression was greater than cytoplasmic IGF-1R in cells with initially high cell surface IGF-1R, and cells with high nuclear IGF-1R established tumors more efficiently in vivo. RNA interferencemediated silencing of IGF-1R in the subpopulation of cells initially harboring higher cell surface and total IGF-1R resulted in significantly reduced anchorage-independent colony formation as compared with cells with initially lower cell surface and total IGF-1R expression. Finally, in accordance with the findings observed in murine aRMS, human aRMS also had robust expression of nuclear IGF-1R Implications: RTK expression status and subcellular localization dynamics are important considerations for personalized medicine.

AB - Since the advent of tyrosine kinase inhibitors as targeted therapies in cancer, several receptor tyrosine kinases (RTK) have been identified as operationally important for disease progression. Rhabdomyosarcoma (RMS) is a malignancy in need of new treatment options; therefore, better understanding of the heterogeneity of RTKs would advance this goal. Here, alveolar RMS (aRMS) tumor cells derived from a transgenic mouse model expressing two such RTKs, platelet-derived growth factor (PDGFR)a and insulin-like growth factor (IGF)-1R, were investigated by fluorescence-activated cell sorting (FACS). Sorted subpopulations that were positive or negative for PDGFRa and IGF-1R dynamically altered their cell surface RTK expression profiles as early as the first cell division. Interestingly, a difference in total PDGFRa expression and nuclear IGF-1R expression was conserved in populations. Nuclear IGF-1R expression was greater than cytoplasmic IGF-1R in cells with initially high cell surface IGF-1R, and cells with high nuclear IGF-1R established tumors more efficiently in vivo. RNA interferencemediated silencing of IGF-1R in the subpopulation of cells initially harboring higher cell surface and total IGF-1R resulted in significantly reduced anchorage-independent colony formation as compared with cells with initially lower cell surface and total IGF-1R expression. Finally, in accordance with the findings observed in murine aRMS, human aRMS also had robust expression of nuclear IGF-1R Implications: RTK expression status and subcellular localization dynamics are important considerations for personalized medicine.

UR - http://www.scopus.com/inward/record.url?scp=84888215121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888215121&partnerID=8YFLogxK

U2 - 10.1158/1541-7786.MCR-12-0598

DO - 10.1158/1541-7786.MCR-12-0598

M3 - Article

VL - 11

SP - 1303

EP - 1313

JO - Molecular Cancer Research

JF - Molecular Cancer Research

SN - 1541-7786

IS - 11

ER -